Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
The definitive Digiday guide to what’s in and out for advertising in 2026
Here’s the definitive guide to what’s in and out in 2026.
‘Less pitching, more listening’: What Amazon is really doing at CES
Amazon’s ad execs come to CES for their annual reality check.
After watching X’s ownership issues play out, marketers brace for TikTok whiplash in 2026
TikTok’s ownership drama has echoes of X (formerly Twitter), but ad performance has kept marketers for fleeing—for now.